Ovation Science Inc.
OVAT
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.10K | 14.50K | 9.80K | 12.00K | 12.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.10K | 14.50K | 9.80K | 12.00K | 12.20K |
| Cost of Revenue | -- | 14.00K | 5.90K | 0.00 | 300.00 |
| Gross Profit | 11.10K | 500.00 | 3.90K | 12.00K | 11.90K |
| SG&A Expenses | 81.30K | 170.50K | 98.40K | 101.20K | 86.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.30K | 184.50K | 104.40K | 101.20K | 87.10K |
| Operating Income | -70.20K | -170.10K | -94.50K | -89.20K | -74.90K |
| Income Before Tax | -76.60K | -172.50K | -97.40K | -96.50K | -84.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -76.60K | -172.50K | -97.40K | -96.50K | -84.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -76.60K | -172.50K | -97.40K | -96.50K | -84.70K |
| EBIT | -70.20K | -170.10K | -94.50K | -89.20K | -74.90K |
| EBITDA | -- | -169.70K | -94.10K | -88.80K | -74.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 38.44M | 36.68M | 35.24M | 34.98M | 34.98M |
| Average Diluted Shares Outstanding | 38.44M | 36.68M | 35.24M | 34.98M | 34.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |